financetom
Business
financetom
/
Business
/
Trilogy Metals Notes Issuance of Right-of-Way Permits for Ambler Access Project in Alaska
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trilogy Metals Notes Issuance of Right-of-Way Permits for Ambler Access Project in Alaska
Oct 24, 2025 4:34 AM

07:03 AM EDT, 10/24/2025 (MT Newswires) -- Trilogy Metals ( TMQ ) Friday provided an update on the Ambler Access Project that would enable the development of the Ambler Mining District in Alaska.

The Alaska Industrial Development and Export Authority (AIDEA), which manages the project, has executed the right-of-way permits for the project with the U.S. Army Corps of Engineers, the National Park Service and the Bureau of Land Management. This formally re-establishes required federal authorizations to advance the project.

With the right-of-way permits in effect, AIDEA plans to proceed with road planning activities, including updated engineering plans and budgets for next year.

The Ambler Access Project is a planned 211-mile, industrial-use-only road from the Upper Kobuk Mineral Projects to the Dalton Highway. Trilogy is advancing exploration at the Upper Kobuk Mineral Projects in Alaska's Ambler Mining District, which contains rich copper-dominant polymetallic deposits.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
Mar 26, 2025
March 26 (Reuters) - Salarius Pharmaceuticals Inc ( SLRX ) : * SALARIUS PHARMACEUTICALS MERGER PARTNER, DECOY THERAPEUTICS, ANNOUNCES ITS NOVEL INHIBITORS SHOW PROMISING IN SILICO ACTIVITY AGAINST MEASLES AND RELATED VIRUSES Source text: Further company coverage: ...
Market Chatter: Couche-Tard Sees Strong Interest In U.S. Stores for Seven & i Deal
Market Chatter: Couche-Tard Sees Strong Interest In U.S. Stores for Seven & i Deal
Mar 26, 2025
08:19 AM EDT, 03/26/2025 (MT Newswires) -- Private equity firms are showing strong interest in buying about 2,000 North American convenience stores that could be divested if Alimentation Couche-Tard Inc. ( ANCTF ) succeeds in its 7.39 trillion yen (US$49 billion) endeavor to buy out Seven & i Holdings Co., the chief financial officer of the Canadian company said, Bloomberg...
Phillips 66 Nominates Four Board Members in Proxy Statement Amid Shareholder Lawsuit
Phillips 66 Nominates Four Board Members in Proxy Statement Amid Shareholder Lawsuit
Mar 26, 2025
08:15 AM EDT, 03/26/2025 (MT Newswires) -- Phillips 66 (PSX) said Wednesday it has nominated four candidates to stand for election to the board of directors ahead of the upcoming annual shareholders' meeting. The company said the nominees include current directors John Lowe and Robert Pease, and new nominees A. Nigel Hearne and Howard Ungerleider, who will replace retiring directors...
India's Reliance to stop buying Venezuelan oil over US tariffs, sources say
India's Reliance to stop buying Venezuelan oil over US tariffs, sources say
Mar 26, 2025
NEW DELHI (Reuters) - India's Reliance Industries, operator of the world's biggest refining complex, will halt Venezuelan oil imports after the United States announced a 25% tariff on nations buying crude from the South American nation, three sources said on Wednesday. The Indian conglomerate, which last year obtained approval from U.S. authorities to purchase oil from the sanctioned producer, imports...
Copyright 2023-2026 - www.financetom.com All Rights Reserved